High Tech Electronic Glasses Allow Legally Blind to Experience Up to 20/20 Vision
Game-changing technology paves way to restored vision for those living with low vision for legal blindness
LOS ANGELES and TORONTO – (Business Wire) – February 15, 2017 — eSight Corporation is pleased to announce the launch of eSight 3, electronic glasses that let the legally blind actually see. The device uses high-tech image processing to provide individuals who are legally blind the opportunity to experience up to 20/20 vision.
Dr. Brian Mech, President and CEO of eSight said, “eSight 3 is a game-changer for the legally blind and low vision community. With eSight 3, people who are visually impaired due to a variety of eye conditions such as macular degeneration, diabetic retinopathy and other diseases which compromise their sight will now have the opportunity to experience a dramatically improved quality of sight and life. To date, users of eSight’s prior generation hardware have reported a greater ability to independently engage in professional, academic or personal activities that were previously out of reach. eSight 3 is a versatile, mobile, wearable and hands-free solution that provides sight without the need for surgery.”
eSight 3 – the company’s newest generation of hardware – gives users unprecedented control over magnification, contrast, brightness, focus and other features that are important for people with low vision. The electronic glasses contain a proprietary camera that projects adjusted video onto two OLED screens in front of the eyes, in real time. Unlike other assistive devices, eSight can be used while walking and while shifting between tasks and environments, without interruptions in the image that can cause dizziness or discomfort. Because no two people see alike (even with the same diagnosis), eSight ships from the factory with customized personal settings suitable for each user. As compared to the previous iteration, eSight 3 is dramatically smaller, lighter, better looking and more comfortable for users. Importantly, eSight 3includes Wi- Fi and HDMI capabilities to stream digital content or even send and receive pictures and videos.
According to the National Federation of the Blind, 24 percent of visually impaired Americans over age 21 do not have a high school diploma or GED and 60 percent of working age, legally blind or low vision Americans are unemployed.
Dr. Robert Devenyi of Toronto’s University Health Clinic believes eSight 3 can improve those odds. He said, “While there are currently no cures for diseases resulting in vision loss, it's literally life-changing to be able to offer this type of technology to people with low vision. eSight 3 not only provides them with dramatically improved sight but also the ability to stay connected to today’s latest technology. This is salient because it means that legally blind users no longer need to purchase specialized computer software or additional assistive technology to keep up in the classroom or in the workplace. eSight 3 really levels the playing field between blind users and their sighted peers.”
As part of its continued commitment to making sight more accessible for those who need it, eSight recently reduced the list price of eSight 3 from $15,000 USD to $9,995 USD. The eSight Affordability Program helps interested consumers secure funding for eSight 3, including: discounts for clinical study participation to those who may qualify, low or no-interest payment plans, tax credits, government support programs, corporate job placements, philanthropic donations and a crowdsourcing fundraising platform.
eSight Eyewear received the FCC Chairman’s Award for Advancement in Accessibility in 2016, and has provided the technology to people with low vision in all stages of life.
To learn more about eSight, visit esighteyewear.com or call 1-855- 837-4448.
About eSight:
eSight was founded in 2006 in order to allow legally blind and low vision people to see and independently carry out virtually all Activities of Daily Living. eSight has locations in Los Angeles, Toronto, Ottawa, and a network of affiliates across the United States. eSight can help a worldwide population of several hundred million people including, but not limited to, individuals living with: macular degeneration, diabetic retinopathy, Stargardt’s disease, ocular albinism, optic nerve hypoplasia, Leber’s hereditary optic neuropathy, cone-rod dystrophy, nystagmus, retinopathy of prematurity as well as those with some forms of glaucoma and retinitis pigmentosa. eSight is registered with the FDA and Health Canada.